0001209191-17-017612.txt : 20170303
0001209191-17-017612.hdr.sgml : 20170303
20170303163652
ACCESSION NUMBER: 0001209191-17-017612
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170302
FILED AS OF DATE: 20170303
DATE AS OF CHANGE: 20170303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ultragenyx Pharmaceutical Inc.
CENTRAL INDEX KEY: 0001515673
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272546083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 415-483-8800
MAIL ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sharp Shalini
CENTRAL INDEX KEY: 0001377202
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36276
FILM NUMBER: 17664253
MAIL ADDRESS:
STREET 1: AGENUS INC.
STREET 2: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-03-02
0
0001515673
Ultragenyx Pharmaceutical Inc.
RARE
0001377202
Sharp Shalini
C/O ULTRAGENYX PHARMACEUTICAL INC.
60 LEVERONI COURT
NOVATO
CA
94949
0
1
0
0
CFO & Executive Vice President
Common Stock
2017-03-02
4
M
0
12000
0.815
A
67887
D
Common Stock
2017-03-02
4
S
0
12000
90.098
D
55887
D
Stock Option (Right to Buy)
0.815
2017-03-02
4
M
0
12000
0.00
D
2022-08-01
Common Stock
12000
32163
D
The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.34 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
1/4th of the option vested one year from May 21, 2012 and then 1/48th monthly thereafter.
/s/ Ruben A. Garcia, attorney-in-fact
2017-03-02